May 16, 2024, Mumbai: Indoco Remedies Limited announced today that, the United States Food and Drug Administration (USFDA) successfully completed inspection of its API Kilo Lab manufacturing facility at Rabale, Navi Mumbai and Indoco Analytical Solutions (IAS) division. The inspection concluded with zero Form 483 observations, reflecting the company’s commitment to maintaining the highest standards of quality and compliance.
“We are extremely happy with the outcome of this inspection. This achievement reflects our relentless focus on quality and compliance in everything we do. We remain committed to ensuring the safety and efficacy of our products while maintaining the trust of our customers and stakeholders”, said Ms. Aditi Panandikar, Managing Director, Indoco Remedies Limited.
